propranolol has been researched along with atomoxetine hydrochloride in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bemis, K; Danuser, H; Thor, KB | 1 |
| Kropp, BP; Springer, JP; Thor, KB | 1 |
| Corbit, LH; Janak, PH | 1 |
| Constantinescu, CC; Mirbolooki, MR; Mukherjee, J; Pan, ML | 1 |
| Li, X; Pan, JS; Yang, FN | 1 |
7 other study(ies) available for propranolol and atomoxetine hydrochloride
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat.
Topics: Anesthesia; Animals; Atomoxetine Hydrochloride; Cats; Dioxanes; Idazoxan; Motor Neurons; Norepinephrine; Prazosin; Propranolol; Propylamines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Reflex; Sympathetic Nervous System; Urinary Tract | 1995 |
Facilitatory and inhibitory effects of selective norepinephrine reuptake inhibitors on hypogastric nerve-evoked urethral contractions in the cat: a prominent role of urethral beta-adrenergic receptors.
Topics: Animals; Atomoxetine Hydrochloride; Cats; Dose-Response Relationship, Drug; Female; Fluoxetine; Muscle Contraction; Norepinephrine; Propranolol; Propylamines; Receptors, Adrenergic, beta; Urethra | 1994 |
Deepened extinction following compound stimulus presentation: noradrenergic modulation.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Brain; Extinction, Psychological; Male; Norepinephrine; Propranolol; Propylamines; Rats; Rats, Sprague-Dawley; Yohimbine | 2011 |
Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Blood Glucose; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Male; Norepinephrine Plasma Membrane Transport Proteins; Obesity; Propranolol; Propylamines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley | 2013 |
Beta-adrenoreceptor blockade abolishes atomoxetine-induced risk taking.
Topics: Adrenergic beta-Antagonists; Animals; Atomoxetine Hydrochloride; Choice Behavior; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Prazosin; Propranolol; Rats; Risk-Taking | 2016 |